VYNE Therapeutics Inc. (VYNE) has 12 identified peers for comparison in the Healthcare sector. Peers include AKTX, AXLA, BCEL, CBIO, CDTX, FWBI and others.
VYNE has a market capitalization of $10.38M, compared to an average peer market cap of $525.19M. VYNE is notably smaller than its average peer.